Mycohydralin (Clotrimazole)

Clotrimazole, the active ingredient in Mycohydralin, is an imidazole antifungal presented as a vaginal formulation for local use. It treats vulvovaginal candidiasis in women by targeting fungal growth within the vaginal mucosa, helping to relieve itching, discharge, and irritation.

GNH USA supplies Mycohydralin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare institutions worldwide.

Clotrimazole is an imidazole antifungal used to treat infections of the vaginal mucosa caused by Candida species.

- Vulvovaginal candidiasis (acute): reduces fungal load and alleviates symptoms such as itching, burning, and abnormal discharge. - Recurrent vulvovaginal candidiasis (maintenance therapy): helps prevent recurrence when used as directed by a healthcare professional. - Vaginal yeast infection (non‑pregnant women): provides rapid symptom relief and eradicates the causative yeast.

Clotrimazole may cause local adverse reactions when applied vaginally.

Common Side Effects: - Vaginal irritation or burning sensation. - Itching or mild pruritus. - Unusual vaginal discharge. - Unpleasant odor from the application site. - Mild abdominal discomfort. - Temporary increased vaginal moisture.

Serious or Rare Side Effects: - Allergic reaction with swelling, rash, or hives. - Severe skin reactions such as Stevens‑Johnson syndrome. - Liver enzyme abnormalities (rare). - Anaphylaxis (very rare).

Before using Mycohydralin, consider the following safety measures. - Pregnancy: consult a healthcare provider before use. - Breastfeeding: discuss potential risks with a physician. - Known allergy to clotrimazole or other imidazoles: avoid use. - Concurrent vaginal medications: do not use simultaneously without professional advice. - Severe hepatic impairment: use with caution under medical supervision. - Store at below 25°C: keep in the original packaging, protect from moisture and heat.

Clotrimazole can interact with other medicines; monitor the following.

Major Interactions (Avoid): - Systemic azole antifungals (e.g., fluconazole): increased risk of toxicity. - Terbinafine: potential antagonistic effect reducing efficacy.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may diminish clotrimazole absorption. - Oral contraceptives: possible slight reduction in effectiveness. - Antacids: generally no significant interaction, but monitor symptoms. - Alcohol: no known direct interaction, but advise moderation.